DNANUDGE Revenue and Competitors
Estimated Revenue & Valuation
- DNANUDGE's estimated annual revenue is currently $19.1M per year.
- DNANUDGE's estimated revenue per employee is $251,000
Employee Data
- DNANUDGE has 76 Employees.
- DNANUDGE grew their employee count by -37% last year.
DNANUDGE's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder & CSO | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | Head Database Algorithms | Reveal Email/Phone |
4 | Head PoC Device | Reveal Email/Phone |
5 | VP, Assay Development | Reveal Email/Phone |
6 | VP Procurement and Supply Chain | Reveal Email/Phone |
7 | General Counsel | Reveal Email/Phone |
8 | EVP Digital | Reveal Email/Phone |
9 | Head Supply Chain | Reveal Email/Phone |
10 | Head Retail B2B Customer Operations | Reveal Email/Phone |
DNANUDGE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.1M | 76 | -37% | N/A | N/A |
#2 | $1.8M | 12 | -33% | N/A | N/A |
#3 | $51.1M | 185 | 7% | N/A | N/A |
What Is DNANUDGE?
DnaNudge is the developer of the world’s first service to use consumers’ own DNA plus lifestyle factors to nudge people towards healthier choices while shopping. The DnaNudge service analyses and maps users’ genetic profile to key nutrition-related health traits such as obesity, diabetes, hypertension and cholesterol, enabling customers to be guided by their DNA towards healthier eating. The service has been developed by world-renowned biomedical engineer Regius Professor Chris Toumazou FRS and published geneticist Dr Maria Karvela. This ground-breaking in-store DNA testing service created to address an epidemic – obesity and Type 2 diabetes – has now been successfully adapted for the fight against a pandemic, with the development of the rapid, lab-free CovidNudge RT-PCR test. CovidNudge can accurately detect COVID-19 and other viruses in just over an hour, without the need for a laboratory, and is now in UK NHS roll-out.
keywords:N/A
N/A
Total Funding
76
Number of Employees
$19.1M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DNANUDGE News
Personalized Retail Nutrition And Wellness Market Report 2022 to 2029 Key Companies with Impact of COVID-19 on Industry -STYR Labs, DNANudge,...
DnaNudge, a London UK-based company focused on genetics testing and medical diagnostics, raised $60M in Series A funding. The round was led by Ventura Capital with participation from Bank Julius Baer. Led by co-fouder and CEO Chris Toumazou, DnaNudge leverages consumers’ own DNA plus lifestyle ...
Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has successfully completed a $60 million Series A investment round led by investment company Ventura Capital. DnaNudge’s first major fund-raising round includes participation from the world’s largest indep ...
Though PCR testing has been established as the gold standard for COVID-19 detection, it remains less accessible than rapid antigen testing, since most PCR tests typically take longer to return results and require lab equipment to do so. A year later, DnaNudge has its sights set on expanding wel ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.2M | 76 | -16% | N/A |
#2 | $11M | 76 | 19% | N/A |
#3 | $11M | 76 | -27% | N/A |
#4 | $17.8M | 76 | 7% | N/A |
#5 | $19.1M | 76 | 4% | N/A |